Impact of Head and Neck Cancer Center Accreditation on Patient Survival Outcomes - Scorecard - MDSpire

Impact of Head and Neck Cancer Center Accreditation on Patient Survival Outcomes

  • By

  • Olaf Schoffer

  • Max Kemper

  • Michael Gerken

  • Veronika Bierbaum

  • Christoph Bobeth

  • Martin Rößler

  • Patrik Dröge

  • Thomas Ruhnke

  • Christian Günster

  • Kees Kleihues-van Tol

  • Chia-Jung Busch

  • Monika Klinkhammer-Schalke

  • Jochen Schmitt

  • January 26, 2026

  • 0 min

Share

Clinical Scorecard: Impact of Head and Neck Cancer Center Accreditation on Patient Survival Outcomes

At a Glance

CategoryDetail
ConditionHead and neck cancers including lip, oral cavity, throat, larynx, nasal cavity, paranasal sinus, salivary gland, and cervical carcinoma of unknown primary
Key MechanismsInterdisciplinary and interprofessional treatment planning, certification of centers based on quality indicators and minimum treatment volume, evidence-based guidelines
Target PopulationPatients diagnosed with head and neck cancers in Germany
Care SettingCertified and non-certified cancer treatment centers in Germany

Key Highlights

  • Head and neck cancers are heterogeneous with variable survival rates depending on location and stage.
  • Certification by the German Cancer Society (DKG) requires comprehensive quality criteria and minimum treatment volumes.
  • The WiZen study evaluates survival outcomes comparing certified versus non-certified centers using nationwide insurance and cancer registry data.

Guideline-Based Recommendations

Diagnosis

  • Use interdisciplinary and interprofessional consultations for comprehensive evaluation prior to treatment.
  • Apply S3 guidelines for specific head and neck cancer subtypes (oral cavity, laryngeal, oro-/hypopharyngeal, salivary gland, nasal/paranasal sinus).

Management

  • Ensure treatment in certified centers meeting DKG standards to optimize outcomes.
  • Incorporate multidisciplinary expertise across all therapeutic modalities.
  • Follow evidence-based oncology guidelines including supportive therapy and management of treatment-related side effects.

Monitoring & Follow-up

  • Utilize cancer registries for systematic case tracking and disease surveillance.
  • Conduct ongoing quality indicator assessments as part of certification maintenance.

Risks

  • Consider treatment-related side effects requiring further therapy.
  • Recognize variability in survival based on tumor location, stage, and treatment quality.

Patient & Prescribing Data

Patients with head and neck cancer treated in Germany from 2009 to 2017

55.27% of new head and neck cancer cases in Germany were treated in DKG-certified facilities, reflecting adherence to certification standards linked to improved survival outcomes.

Clinical Best Practices

  • Prioritize treatment in certified centers to ensure adherence to quality standards and multidisciplinary care.
  • Implement comprehensive interdisciplinary treatment planning and follow-up to detect recurrences early.
  • Use nationally developed S3 guidelines tailored to specific head and neck cancer subtypes.
  • Maintain certification through continuous quality improvement and meeting defined volume and quality indicators.

Related Resources & Content

Original Source(s)

Related Content